Fate of the abstracts presented at three Spanish clinical pharmacology congresses and reasons for unpublished research E. MontanéX. Vidal Special Article 06 January 2007 Pages: 103 - 111
The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers S. EfratiM. AverbukhA. Golik Clinical Trial 03 January 2007 Pages: 113 - 121
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension Angelo TremblayJean-Philippe ChaputJean-Pierre Després Clinical Trials 03 January 2007 Pages: 123 - 134
The effect of MK-0524, a prostaglandin D2 receptor antagonist, on prostaglandin D2-induced nasal airway obstruction in healthy volunteers A. Van HeckenM. DepréJ. N. de Hoon Pharmacodynamics 03 January 2007 Pages: 135 - 141
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations Tsukasa UnoTakenori NiiokaTomonori Tateishi Pharmacogenetics 04 January 2007 Pages: 143 - 149
Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist Paul L. M. van GiersbergenJasper Dingemanse Pharmacokinetics and Disposition 25 April 2006 Pages: 151 - 158
Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl Robert Z. HarrisMargaret SalfiDesmond Padhi Pharmacokinetics and Disposition 08 May 2006 Pages: 159 - 163
Plasma protein distribution and its impact on pharmacokinetics of liposomal amphotericin B in paediatric patients with malignant diseases Ying HongPeter J. ShawAndrew J. McLachlan Pharmacokinetics and Disposition 19 December 2006 Pages: 165 - 172
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers Annika AllqvistJun MiuraRajaa A. Mirghani Pharmacokinetics and Disposition 03 January 2007 Pages: 173 - 179
Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients Maurits E. L. ArbouwKris L. L. MovigToine C. G. Egberts Pharmacoepidemiology and Prescription 03 January 2007 Pages: 181 - 187
Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC) J. HeadleyK. Northstone Pharmacoepidemiology and Prescription Open access 03 January 2007 Pages: 189 - 195
Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994–2003 Paola DeambrosisCristina SaraminAlessandro Chinellato Pharmacoepidemiology and Prescription 03 January 2007 Pages: 197 - 203
Incorrect use of orlistat and sibutramine in clinical practice Anna DahlinBjörn Beermann Pharmacoepidemiology and Prescription 05 January 2007 Pages: 205 - 209
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes Yuji ManoTakashi UsuiHidetaka Kamimura Short Communication 03 January 2007 Pages: 211 - 216
Effect of CYP2D6 genotype on flecainide pharmacokinetics in Japanese patients with supraventricular tachyarrhythmia Kosuke DokiMasato HommaYukinao Kohda Erratum 15 December 2006 Pages: 217 - 218
CPT 2008, The IXth World Conference on Clinical Pharmacology and Therapeutics Announcement 03 January 2007 Pages: 219 - 219